Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
about
Mitochondrial control of cell bioenergetics in Parkinson's disease.Mutant A53T α-Synuclein Improves Rotarod Performance Before Motor Deficits and Affects Metabolic Pathways.Diet-induced obesity accelerates the onset of terminal phenotypes in α-synuclein transgenic mice.Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects.Regulation of Hippocampal Synaptic Function by the Metabolic Hormone, Leptin: Implications for Health and Neurodegenerative DiseaseOverexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice
P2860
Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
@en
Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
@nl
type
label
Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
@en
Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
@nl
prefLabel
Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
@en
Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice.
@nl
P2093
P2860
P1476
Metabolic abnormalities and hypoleptinemia in α-synuclein A53T mutant mice
@en
P2093
Bronwen Martin
Kathleen J Griffioen
Mark P Mattson
Richard G Spencer
Sarah M Rothman
Wei-Na Cong
P2860
P304
P356
10.1016/J.NEUROBIOLAGING.2013.10.088
P577
2013-10-22T00:00:00Z